Abstract
Alzheimer’s disease (AD) is acknowledged as one of the most common types of dementia. Various brain regions were found to associated with AD pathology. Precuneus and fusiform gyrus are two notable regions whose role has been implicated in cognitive function. However, a thorough investigation was lacking to link these regions with AD pathology. In this study, we conducted a comprehensive radiomic based investigation using magnetic resonance imaging (MRI) scans to link precuneus and fusiform gyrus with AD pathology. We obtained T1 weighted MR scans of AD (n=133), MCI (n=311) and CN (n=195) subjects from ADNI database at three different time points (i.e., 0, 6 and 12 months). Then, we conducted statistical analysis to compare these features among AD, MCI and CN subjects. We found significant decline in gray matter volume (GMV) and cortical thickness of both precuneus and fusiform gyrus in AD as compared to the MCI and CN subjects. Further, we utilized these features to develop machine learning classifiers to classify AD from MCI and CN subjects and achieved accuracy of 97.78% and 94.41% respectively. These results strengthen the connection of precuneus and fusiform gyrus with AD pathology and opens a new avenue of AD research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the seed research grant from the Indian Institute of Technology Hyderabad.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
9. Data Availability
All the datasets used in this study are available on ADNI database website (http://adni.loni.usc.edu/).
